Propofol protects H9C2 cells against hypoxia/reoxygenation injury through miR-449a and NR4A2

Propofol has been revealed to protect cardiomyocytes against myocardial ischemia injury, although the underlying mechanism remains incompletely understood. H9C2 cells were used to generate a hypoxia/reoxygenation (H/R) in vitro model for the present study. Reverse transcription-quantitative PCR and...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Qiu, Xie, Yingxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406901/
https://www.ncbi.nlm.nih.gov/pubmed/34475971
http://dx.doi.org/10.3892/etm.2021.10615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406901/
https://www.ncbi.nlm.nih.gov/pubmed/34475971
http://dx.doi.org/10.3892/etm.2021.10615

Ejemplares similares